1. Home
  2. TAYD vs FATE Comparison

TAYD vs FATE Comparison

Compare TAYD & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TAYD
  • FATE
  • Stock Information
  • Founded
  • TAYD 1955
  • FATE 2007
  • Country
  • TAYD United States
  • FATE United States
  • Employees
  • TAYD N/A
  • FATE N/A
  • Industry
  • TAYD Industrial Machinery/Components
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TAYD Industrials
  • FATE Health Care
  • Exchange
  • TAYD Nasdaq
  • FATE Nasdaq
  • Market Cap
  • TAYD 132.1M
  • FATE 116.5M
  • IPO Year
  • TAYD N/A
  • FATE 2013
  • Fundamental
  • Price
  • TAYD $43.51
  • FATE $1.00
  • Analyst Decision
  • TAYD
  • FATE Buy
  • Analyst Count
  • TAYD 0
  • FATE 7
  • Target Price
  • TAYD N/A
  • FATE $3.92
  • AVG Volume (30 Days)
  • TAYD 5.9K
  • FATE 2.2M
  • Earning Date
  • TAYD 01-02-2026
  • FATE 11-13-2025
  • Dividend Yield
  • TAYD N/A
  • FATE N/A
  • EPS Growth
  • TAYD N/A
  • FATE N/A
  • EPS
  • TAYD 2.72
  • FATE N/A
  • Revenue
  • TAYD $44,593,219.00
  • FATE $7,137,000.00
  • Revenue This Year
  • TAYD $10.81
  • FATE N/A
  • Revenue Next Year
  • TAYD $8.37
  • FATE N/A
  • P/E Ratio
  • TAYD $15.87
  • FATE N/A
  • Revenue Growth
  • TAYD N/A
  • FATE N/A
  • 52 Week Low
  • TAYD $29.50
  • FATE $0.66
  • 52 Week High
  • TAYD $53.73
  • FATE $3.50
  • Technical
  • Relative Strength Index (RSI)
  • TAYD 44.39
  • FATE 33.11
  • Support Level
  • TAYD $43.50
  • FATE $1.00
  • Resistance Level
  • TAYD $50.51
  • FATE $1.16
  • Average True Range (ATR)
  • TAYD 1.80
  • FATE 0.12
  • MACD
  • TAYD -0.06
  • FATE -0.05
  • Stochastic Oscillator
  • TAYD 0.27
  • FATE 1.80

About TAYD Taylor Devices Inc.

Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: